National Cancer Institute director named acting FDA commissioner

Norman E. “Ned” Sharpless, MD, director of National Cancer Institute, will replace resigning FDA commissioner Scott Gottlieb, MD, according to a tweet from Gottlieb.
“I’m delighted by the announcement from [HHS Secretary Alex Azar] that [Sharpless] will serve as acting commissioner of FDA. Ned is a friend to FDA, a great public health champion, a dedicated physician, and will be warmly welcomed into his new role. FDA will benefit greatly from his leadership,” the tweet read.
The announcement was also confirmed by HHS' public affairs office. 
Sharpless has

Full Story →